Sentry-Q: Quantum-Powered Security Platform Leads the Way in Meeting New U.S. Healthcare Cybersecurity Proposed Standards
Quantum eMotion (QNCCF) has launched Sentry-Q, a quantum-powered security platform designed to protect digital therapeutics against cyber threats. The platform's release aligns with new U.S. healthcare cybersecurity regulations proposed in response to recent major healthcare data breaches at organizations like Ascension and UnitedHealth.
Sentry-Q utilizes pure Entropy-as-a-Service (EaaS) generated by QRNG2 technology, integrated with classical and post-quantum cryptography. The platform meets the latest U.S. healthcare cybersecurity recommendations and has achieved ISO/IEC 27001:2022 certification. The company has also granted stock options to its CTO (600,000 shares) and CFO (350,000 shares).
Quantum eMotion (QNCCF) ha lanciato Sentry-Q, una piattaforma di sicurezza basata su quantum progettata per proteggere le terapie digitali dalle minacce informatiche. Il rilascio della piattaforma è in linea con le nuove normative statunitensi sulla sicurezza informatica nel settore sanitario, proposte in risposta ai recenti gravi violazioni dei dati sanitari in organizzazioni come Ascension e UnitedHealth.
Sentry-Q utilizza pure Entropy-as-a-Service (EaaS) generata dalla tecnologia QRNG2, integrata con crittografia classica e post-quantistica. La piattaforma soddisfa le ultime raccomandazioni statunitensi sulla sicurezza informatica nel settore sanitario e ha ottenuto la certificazione ISO/IEC 27001:2022. L'azienda ha anche concesso opzioni di acquisto di azioni al suo CTO (600.000 azioni) e al CFO (350.000 azioni).
Quantum eMotion (QNCCF) ha lanzado Sentry-Q, una plataforma de seguridad impulsada por quantum diseñada para proteger las terapias digitales contra amenazas cibernéticas. El lanzamiento de la plataforma coincide con las nuevas regulaciones de ciberseguridad en el sector salud de EE. UU. propuestas en respuesta a recientes violaciones importantes de datos de salud en organizaciones como Ascension y UnitedHealth.
Sentry-Q utiliza pure Entropy-as-a-Service (EaaS) generada por la tecnología QRNG2, integrada con criptografía clásica y post-cuántica. La plataforma cumple con las últimas recomendaciones de ciberseguridad en el sector salud de EE. UU. y ha obtenido la certificación ISO/IEC 27001:2022. La empresa también ha otorgado opciones sobre acciones a su CTO (600.000 acciones) y a su CFO (350.000 acciones).
Quantum eMotion (QNCCF)는 사이버 위협으로부터 디지털 치료제를 보호하기 위해 설계된 양자 기반 보안 플랫폼인 Sentry-Q를 출시했습니다. 이 플랫폼의 출시는 최근 Ascension과 UnitedHealth와 같은 조직에서 발생한 주요 의료 데이터 유출에 대응하여 제안된 미국의 새로운 의료 사이버 보안 규정과 일치합니다.
Sentry-Q는 QRNG2 기술로 생성된 pure Entropy-as-a-Service (EaaS)를 사용하며, 고전 및 포스트 양자 암호화와 통합되어 있습니다. 이 플랫폼은 최신 미국 의료 사이버 보안 권고 사항을 충족하며 ISO/IEC 27001:2022 인증을 획득했습니다. 이 회사는 CTO에게 600,000주, CFO에게 350,000주에 대한 주식 옵션도 부여했습니다.
Quantum eMotion (QNCCF) a lancé Sentry-Q, une plateforme de sécurité alimentée par la technologie quantique, conçue pour protéger les thérapies numériques contre les menaces cybernétiques. Le lancement de la plateforme est en accord avec les nouvelles réglementations américaines en matière de cybersécurité dans le secteur de la santé, proposées en réponse à des violations majeures récentes des données de santé dans des organisations telles qu'Ascension et UnitedHealth.
Sentry-Q utilise pure Entropy-as-a-Service (EaaS) générée par la technologie QRNG2, intégrée avec la cryptographie classique et post-quantique. La plateforme répond aux dernières recommandations américaines en matière de cybersécurité dans le secteur de la santé et a obtenu la certification ISO/IEC 27001:2022. L'entreprise a également accordé des options d'achat d'actions à son CTO (600 000 actions) et à son CFO (350 000 actions).
Quantum eMotion (QNCCF) hat Sentry-Q eingeführt, eine quantenbasierte Sicherheitsplattform, die entwickelt wurde, um digitale Therapien vor Cyber-Bedrohungen zu schützen. Die Veröffentlichung der Plattform steht im Einklang mit neuen US-Vorschriften zur Cyber-Sicherheit im Gesundheitswesen, die als Reaktion auf kürzliche schwerwiegende Datenverletzungen im Gesundheitswesen bei Organisationen wie Ascension und UnitedHealth vorgeschlagen wurden.
Sentry-Q nutzt pure Entropy-as-a-Service (EaaS), das durch die QRNG2-Technologie generiert wird und mit klassischer sowie post-quanter Kryptographie integriert ist. Die Plattform erfüllt die neuesten Empfehlungen zur Cyber-Sicherheit im US-Gesundheitswesen und hat die Zertifizierung ISO/IEC 27001:2022 erlangt. Das Unternehmen hat auch Optionen für Aktien an seinen CTO (600.000 Aktien) und CFO (350.000 Aktien) gewährt.
- Platform meets new U.S. healthcare cybersecurity regulations
- Achieved ISO/IEC 27001:2022 certification for security management
- Successfully commercialized Sentry-Q platform
- Stock dilution through executive stock option grants of 950,000 shares
Montreal, Quebec--(Newsfile Corp. - December 30, 2024) - Quantum eMotion (TSXV: QNC) (OTCQB: QNCCF) (QeM) recently announced the commercialization of its quantum-powered security platform, Sentry-Q, designed to fortify digital therapeutics (DTx) against advanced cyber threats. This launch is timely, coinciding with newly proposed healthcare cybersecurity regulations aimed at addressing rising vulnerabilities and underscoring the urgency of safeguarding healthcare systems.
Last week, the U.S. government proposed new cybersecurity regulations to mitigate the impact of healthcare data breaches. This initiative responds to significant cyberattacks on healthcare organizations such as Ascension and UnitedHealth, which have compromised the sensitive information of millions of Americans. The proposals include measures such as enhanced data encryption to prevent unauthorized access even if data is leaked and implementing compliance checks to ensure that networks adhere to cybersecurity standards (https://www.hhs.gov/about/news/2024/12/27/hhs-office-civil-rights-proposes-measures-strengthen-cybersecurity-health-care-under-hipaa.html).
QeM's cutting-edge technology fully meets the latest U.S. healthcare cybersecurity recommendations. Its Sentry-Q platform harnesses the power of pure Entropy-as-a-Service (EaaS), generated by its advanced QRNG2 technology, seamlessly integrated with classical and post-quantum cryptography (PQC). This robust approach ensures the secure transmission of sensitive healthcare data, providing real-time protection and safeguarding confidentiality against both current and emerging quantum threats.
By meeting regulatory requirements, QeM's technology helps healthcare organizations proactively counter future threats while advancing secure digital transformation. QeM has achieved the prestigious ISO/IEC 27001:2022 certification. This certification encompasses Quantum eMotion's security management of applications and systems for its quantum-based cybersecurity software and hardware solutions, including cryptographic solutions.
On December 13, 2024 the Board of QeM granted Edward Lawrence Moore, CTO, 600,000 options to purchase common shares, and Marc Rousseau, CFO was granted 350,000 options to purchase common shares.
About QeM
The Company aims to address the growing demand for affordable hardware and software security for connected devices. QeM has become a pioneering force in classical and quantum cybersecurity solutions thanks to its patented Quantum Random Number Generator, a security solution that exploits the built-in unpredictability of quantum mechanics and promises to provide enhanced protection for high-value assets and critical systems.
The Company intends to target highly valued Financial Services, Healthcare, Blockchain Applications, Cloud-Based IT Security Infrastructure, Classified Government Networks and Communication Systems, Secure Device Keying (IOT, Automotive, Consumer Electronics) and Quantum Cryptography.
For further information, please visit our website at https://www.quantumemotion.com/ or contact:
Francis Bellido, Chief Executive Officer
Tel: 514.956.2525
Email: info@quantumemotion.com
Website: www.quantumemotion.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release may contain forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to vary materially from targeted results. Such risks and uncertainties include those described in the Corporation's periodic reports including the annual report or in the filings made by Quantum from time to time with securities regulatory authorities.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235477
FAQ
What is Quantum eMotion's (QNCCF) Sentry-Q platform?
How does QNCCF's Sentry-Q comply with new U.S. healthcare regulations?
What certifications has QNCCF's Sentry-Q platform received?
How many stock options did QNCCF grant to executives in December 2024?
